Safety

FDA Approves Risankizumab, Adds Stronger Warning to Sleep Medications

May 29, 2019 • By Michele B. Kaufman, PharmD, BCGP

FDA Issues Boxed Warning for Febuxostat & Approves Colchicine for Gout Flare

March 12, 2019 • By Michele B. Kaufman, PharmD, BCGP

Safety Risk with Higher Dose Tofacitnib

March 6, 2019 • By Michele B. Kaufman, PharmD, BCGP

FDA Update: Priority Review for Non-Opioid Treatment & New Warning for Fluoroquinolones

January 23, 2019 • By Michele B. Kaufman, PharmD, BCGP

ah_designs / shutterstock.com

The Perils of Pain Meds Revisited

December 18, 2018 • By Stephen G. Gelfand, MD, FACP, FACR

Phase 2 Results for Mavrilimumab Are In

November 19, 2018 • By Mary Beth Nierengarten

TH Foto-Werbung / Science Source

Turmeric: The Evidence for Therapeutic Use for Arthritis

November 19, 2018 • By Samantha C. Shapiro, MD

FDA Issues Safety Warning

September 25, 2018 • By Michele B. Kaufman, PharmD, BCGP

HCQ Debate: Should Dose Be No More Than 5 mg/kg in All SLE Patients?

September 20, 2018 • By From the College

A Comprehensive Review of NSAID Cardiovascular Toxicity

A Comprehensive Review of NSAID Cardiovascular Toxicity

July 18, 2018 • By Deepan S. Dalal, MD, MPH, Maureen Dubreuil, MD, MS, & David T. Felson, MD, MPH

1
2
3
…
16
Next Page »